IRIX (IRIDEX) Cyclically Adjusted Revenue per Share: $4.01 (As of Mar. 2026)


IRIX IRIDEX Corp IRIX
61 GF Score
Price $1.17
GF Value $1.70
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is IRIDEX Cyclically Adjusted Revenue per Share?

IRIDEX IRIX +2.18% 61 Cyclically Adjusted Revenue per Share is $4.01 as of Mar. 2026. GuruFocus rates IRIX with a GF Score™ of 61/100 and a GF Value™ of $1.70 (Possible Value Trap). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

IRIDEX's adjusted revenue per share for the three months ended in Mar. 2026 was $0.682. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $4.01 for the trailing ten years ended in Mar. 2026.

During the past 12 months, IRIDEX's average Cyclically Adjusted Revenue Growth Rate was -3.40% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -2.40% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 0.30% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was -1.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of IRIDEX was 8.80% per year. The lowest was -4.90% per year. And the median was -1.50% per year.

As of today (2026-07-02), IRIDEX's current stock price is $1.17. IRIDEX's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was $4.01. IRIDEX's Cyclically Adjusted PS Ratio of today is 0.29.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of IRIDEX was 3.46. The lowest was 0.21. And the median was 0.65.


IRIDEX  (NAS:IRIX) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

IRIDEX's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1.17/4.01
=0.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of IRIDEX was 3.46. The lowest was 0.21. And the median was 0.65.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


IRIDEX Cyclically Adjusted Revenue per Share Related Terms


IRIDEX Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for IRIDEX's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IRIDEX Cyclically Adjusted Revenue per Share Chart

IRIDEX Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.17 4.33 4.30 4.17 4.03

IRIDEX Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.15 4.15 4.12 4.03 4.01

IRIX vs ICCM, LFWD, GTHP: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, IRIDEX's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IRIDEX Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, IRIDEX's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where IRIDEX's Cyclically Adjusted PS Ratio falls into.


IRIX
61GF Score
IRIDEX Corp IRIX
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IRIDEX Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, IRIDEX's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.682/330.2130*330.2130
=0.682

Current CPI (Mar. 2026) = 330.2130.

IRIDEX Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 1.181 241.018 1.618
201609 0.966 241.428 1.321
201612 1.200 241.432 1.641
201703 0.910 243.801 1.233
201706 0.866 244.955 1.167
201709 0.939 246.819 1.256
201712 0.884 246.524 1.184
201803 0.818 249.554 1.082
201806 0.885 251.989 1.160
201809 0.949 252.439 1.241
201812 0.843 251.233 1.108
201903 0.777 254.202 1.009
201906 0.764 256.143 0.985
201909 0.775 256.759 0.997
201912 0.853 256.974 1.096
202003 0.654 258.115 0.837
202006 0.451 257.797 0.578
202009 0.634 260.280 0.804
202012 0.885 260.474 1.122
202103 0.834 264.877 1.040
202106 0.823 271.696 1.000
202109 0.838 274.310 1.009
202112 0.961 278.802 1.138
202203 0.843 287.504 0.968
202206 0.865 296.311 0.964
202209 0.915 296.808 1.018
202212 0.950 296.797 1.057
202303 0.857 301.836 0.938
202306 0.802 305.109 0.868
202309 0.792 307.789 0.850
202312 0.767 306.746 0.826
202403 0.724 312.332 0.765
202406 0.776 314.175 0.816
202409 0.698 315.301 0.731
202412 0.763 315.605 0.798
202503 0.711 319.799 0.734
202506 0.808 322.561 0.827
202509 0.734 324.800 0.746
202512 0.856 324.054 0.872
202603 0.682 330.213 0.682

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $4.01 mean?
IRIDEX (IRIX) has a Cyclically Adjusted Revenue per Share of $4.01 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on IRIDEX and its competitors.
Is IRIDEX's Cyclically Adjusted Revenue per Share too high?
IRIDEX's current Cyclically Adjusted Revenue per Share is $4.01. Overall, IRIDEX has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does IRIDEX's Cyclically Adjusted Revenue per Share compare to ICCM and LFWD?
IRIDEX's Cyclically Adjusted Revenue per Share of $4.01 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on IRIDEX and its competitors. IRIDEX's current Cyclically Adjusted Revenue per Share is $4.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IRIDEX stock overvalued right now?
Based on GuruFocus' analysis, IRIDEX (IRIX) is currently considered Possible Value Trap. The stock's GF Value™ is $1.70, compared to a current price of $1.17 — trading 31.2% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is $4.01. IRIDEX's overall GF Score™ is 61/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For IRIDEX (IRIX), the current Cyclically Adjusted Revenue per Share is $4.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IRIDEX (IRIX) Overvalued in 2026?

Based on GuruFocus' analysis, IRIDEX stock appears to be undervalued. The current stock price of $1.17 is trading 31.2% below its estimated GF Value™ of $1.70. GuruFocus considers IRIDEX to be Possible Value Trap.

Key valuation signals for IRIX:

  • Cyclically Adjusted Revenue per Share: $4.01
  • GF Value™: $1.70 vs. price of $1.17 (31.2% below fair value)
  • GF Score™: 61/100 with 3 warning signs

No single metric tells the full story. See the IRIX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


IRIDEX Business Description

Address 1212 Terra Bella Avenue, Mountain View, CA, USA, 94043
IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
61GF Score

Get the complete analysis for IRIX

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.17
Price
$1.70
GF Value